180 related articles for article (PubMed ID: 33571830)
1. Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors.
Legigan T; Migianu-Griffoni E; Redouane MA; Descamps A; Deschamp J; Gager O; Monteil M; Barbault F; Lecouvey M
Eur J Med Chem; 2021 Mar; 214():113241. PubMed ID: 33571830
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
[TBL] [Abstract][Full Text] [Related]
4. α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Matthiesen RA; Varney ML; Xu PC; Rier AS; Wiemer DF; Holstein SA
Bioorg Med Chem; 2018 Jan; 26(2):376-385. PubMed ID: 29248353
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
7. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
9. Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Fairweather AER; Goetz DB; Schroeder CM; Bhuiyan NH; Varney ML; Wiemer DF; Holstein SA
Bioorg Med Chem; 2021 Aug; 44():116307. PubMed ID: 34298413
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
[TBL] [Abstract][Full Text] [Related]
13. Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies.
El-Sherief HAM; Youssif BGM; Bukhari SNA; Abdel-Aziz M; Abdel-Rahman HM
Bioorg Chem; 2018 Feb; 76():314-325. PubMed ID: 29227915
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N
Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234
[TBL] [Abstract][Full Text] [Related]
15. 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors.
Pitucha M; Janeczko M; Klimek K; Fornal E; Wos M; Pachuta-Stec A; Ginalska G; Kaczor AA
Bioorg Chem; 2020 Jun; 99():103806. PubMed ID: 32279038
[TBL] [Abstract][Full Text] [Related]
16. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies.
Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P
Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245
[TBL] [Abstract][Full Text] [Related]
17. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
[TBL] [Abstract][Full Text] [Related]
18. Unveiling novel diphenyl-1H-pyrazole based acrylates tethered to 1,2,3-triazole as promising apoptosis inducing cytotoxic and anti-inflammatory agents.
Khan MF; Anwer T; Bakht A; Verma G; Akhtar W; Alam MM; Rizvi MA; Akhter M; Shaquiquzzaman M
Bioorg Chem; 2019 Jun; 87():667-678. PubMed ID: 30953886
[TBL] [Abstract][Full Text] [Related]
19. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
20. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]